Swiss National Bank

Bank

Position in ANNX — Annexon, Inc.

CIK 1582202 ZURICH, V8

Position in ANNX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,396,666

+$89,226 QoQ

Shares Held

244,600

+3.6% QoQ

Ownership

0.120%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#72

of 216 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. ANNX ranks #122 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	717,440	$356,373,971
2	REGN	Regeneron Pharmaceuticals, Inc.	293,020	$182,709,690
3	ALNY	Alnylam Pharmaceuticals, Inc.	374,080	$112,609,302
4	RVMD	Revolution Medicines, Inc.	456,331	$85,461,669
5	RPRX	Royalty Pharma plc	1,159,800	$65,029,986
6	INSM	INSMED Inc	593,512	$63,280,249
7	INCY	Incyte Corp	476,874	$54,058,436
8	MRNA	Moderna, Inc.	679,900	$47,613,397

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,396,666	244,600	+3.6%	Shares	Sole	2026-08-11
2026-03-31	$1,307,440	236,000	+74.8%	Shares	Sole	2026-05-07
2025-03-31	$260,550	135,000	0.0%	Shares	Sole	2025-05-12
2024-12-31	$692,550	135,000	+147.7%	Shares	Sole	2025-02-10
2022-03-31	$148,785	54,500	+7.7%	Shares	Sole	2022-05-09
2021-12-31	$581,394	50,600	+50.6%	Shares	Sole	2022-02-08
2021-09-30	$625,296	33,600	0.0%	Shares	Sole	2021-11-08
2021-06-30	$756,336	33,600	+11.3%	Shares	Sole	2021-08-06
2021-03-31	$840,768	30,200	0.0%	Shares	Sole	2021-05-07
2020-12-31	$755,906	30,200	—	Shares	Sole	2021-02-05
No filing history on record for this holder in this stock.